|
1
|
Graubert TA and Mardis ER: Genomics of
acute myeloid leukemia. Cancer J. 17:487–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosshard R, O'Reilly K, Ralston S, Chadda
S and Cork D: Systematic reviews of economic burden and
health-related quality of life in patients with acute myeloid
leukemia. Cancer Treat. Rev. 69:224–232. 2018.
|
|
3
|
Yang X and Wang J: Precision therapy for
acute myeloid leukemia. J Hematol Oncol. 11:32018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mao J, Li S, Zhao H, Zhu Y, Hong M, Zhu H,
Qian S and Li J: Effects of chidamide and its combination with
decitabine on proliferation and apoptosis of leukemia cell lines.
Am J Transl Res. 10:2567–2578. 2018.PubMed/NCBI
|
|
5
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang C, Bai G, Zhu W, Bai D and Bi G:
Identification of miRNA-mRNA network associated with acute myeloid
leukemia survival. Med Sci Monit. 23:4705–4714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Cai X, Liu E, Tian X and Tian C:
MicroRNA-18a promotes proliferation and metastasis in
hepatocellular carcinoma via targeting KLF4. Oncotarget.
8:68263–68269. 2017.PubMed/NCBI
|
|
8
|
Tian C, Wu H, Li C, Tian X, Sun Y, Liu E,
Liao X and Song W: Downreguation of FoxM1 by miR-214 inhibits
proliferation and migration in hepatocellular carcinoma. Gene Ther.
25:312–319. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hartmann JU, Bräuer-Hartmann D, Kardosova
M, Wilke F, Schödel C, Gerloff D, Katzerke C, Krakowsky R, Namasu
CY, Bill M, et al: MicroRNA-143 targets ERK5 in granulopoiesis and
predicts outcome of patients with acute myeloid leukemia. Cell
Death Dis. 9:8142018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Y, Zou Y, Lin L, Ma X and Chen H:
Identification of serum miR-34a as a potential biomarker in acute
myeloid leukemia. Cancer Biomark. 22:799–805. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding Q, Wang Q, Ren Y, Zhu HQ and Huang Z:
MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute
myeloid leukemia cells. Biochem Cell Biol. 25:(Epub ahead of
print). 2018.
|
|
12
|
Badr M, Said H, Louka ML, Elghazaly HA,
Gaballah A and Atef Abd El Mageed M: MicroRNA-21 as a predictor and
prognostic factor for trastuzumab therapy in human epidermal growth
factor receptor 2-positive metastatic breast cancer. J Cell
Biochem. 120:3459–3466. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riccioni R, Lulli V, Castelli G, Biffoni
M, Tiberio R, Pelosi E, Lo-Coco F and Testa U: miR-21 is
overexpressed in NPM1-mutant acute myeloid leukemias. Leuk Res.
39:221–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Sui X, Hu X and Hu Z: Overexpression
of KLF5 inhibits puromycin-induced apoptosis of podocytes. Mol Med
Rep. 18:3843–3849. 2018.PubMed/NCBI
|
|
15
|
Ma Y, Wang Q, Liu F, Ma X, Wu L, Guo F,
Zhao S, Huang F and Qin G: KLF5 promotes the tumorigenesis and
metastatic potential of thyroid cancer cells through the NF-κB
signaling pathway. Oncol Rep. 40:2608–2618. 2018.PubMed/NCBI
|
|
16
|
Jia L, Zhou Z, Liang H, Wu J, Shi P, Li F,
Wang Z, Wang C, Chen W, Zhang H, et al: KLF5 promotes breast cancer
proliferation, migration and invasion in part by upregulating the
transcription of TNFAIP2. Oncogene. 35:2040–2051. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong T, Cui L, Wang H, Wang H and Han N:
Knockdown of KLF5 suppresses hypoxia-induced resistance to
cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis
through inactivation of the PI3K/Akt/mTOR pathway. J Transl Med.
16:1642018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du C, Gao Y, Xu S, Jia J, Huang Z, Fan J,
Wang X, He D and Guo P: KLF5 promotes cell migration by
up-regulating FYN in bladder cancer cells. FEBS Lett. 590:408–418.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Diakiw SM, Kok CH, To LB, Lewis ID, Brown
AL and D'Andrea RJ: The granulocyte-associated transcription factor
Krüppel-like factor 5 is silenced by hypermethylation in acute
myeloid leukemia. Leuk Res. 36:110–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C, Shao T, Zhang H, Zhang N, Shi X,
Liu X, Yao Y, Xu L, Zhu S, Cao J, et al: MiR-425 expression
profiling in acute myeloid leukemia might guide the treatment
choice between allogeneic transplantation and chemotherapy. J
Transl Med. 16:2672018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Abraham JM, Cheng Y, Wang Z, Wang
Z, Zhang G, Ashktorab H, Smoot DT, Cole RN, Boronina TN, et al:
Synthetic circular RNA functions as a miR-21 sponge to suppress
gastric carcinoma cell proliferation. Mol Ther Nucleic Acids.
13:312–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding T, Cui P, Zhou Y, Chen C, Zhao J,
Wang H, Guo M, He Z and Xu L: Antisense oligonucleotides against
miR-21 inhibit the growth and metastasis of colorectal carcinoma
via the DUSP8 pathway. Mol Ther Nucleic Acids. 13:244–255. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Yang H and Ren L: MiR-21 promoted
proliferation and migration in hepatocellular carcinoma through
negative regulation of Navigator-3. Biochem Biophys Res Commun.
464:1228–1234. 2015. View Article : Google Scholar : PubMed/NCBI
|
